PNC Financial Services Group
MACK

PNC Financial Services Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

PNC Financial Services Group’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-165
Closed -$2.44K – 4985
2024
Q1 		$2.44K Buy
165
+157
+1,963% +$2.21K ﹤0.01% 4152
2023
Q4 		$107 Buy
+8
New +$101 ﹤0.01% 4516
2021
Q2 		– Sell
-200
Closed -$1K – 4397
2021
Q1 		$1K Buy
+200
New +$1.43K ﹤0.01% 4082
2017
Q1 		– Sell
-4,057
Closed -$130K – 4300
2016
Q4 		$130K Hold
4,057
– – ﹤0.01% 2329
2016
Q3 		$202K Sell
4,057
-585
-13% -$24.3K ﹤0.01% 2091
2016
Q2 		$197K Sell
4,642
-26
-0.6% -$1.42K ﹤0.01% 2101
2016
Q1 		$306K Buy
4,668
+3
+0.1% +$157 ﹤0.01% 1842
2015
Q4 		$291K Buy
4,665
+1,195
+34% +$84.1K ﹤0.01% 1844
2015
Q3 		$233K Buy
3,470
+884
+34% +$72.2K ﹤0.01% 2030
2015
Q2 		$251K Buy
2,586
+31
+1% +$2.95K ﹤0.01% 2076
2015
Q1 		$238K Buy
2,555
+2,511
+5,707% +$214K ﹤0.01% 2110
2014
Q4 		$4K Buy
+44
New +$3.21K ﹤0.01% 3626
2013
Q4 		– Sell
-1,879
Closed -$56K – 3699
2013
Q3 		$56K Hold
1,879
– – ﹤0.01% 2436
2013
Q2 		$100K Buy
+1,879
New +$82.4K ﹤0.01% 2124

Other funds holding MACK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
RA
Rise Advisors Rochester, New York $355M AUM 20.51% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PNC Financial Services Group's MACK Position: Q2 2024 in Review

PNC Financial Services Group sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 165 shares — an estimated $2.44K sold.

PNC Financial Services Group first reported a position in MACK in Q2 2013 and held it in 14 quarters. The position peaked at $306K in Q1 2016. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.

  • PNC Financial Services Group reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 165 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $2.44K.
  • PNC Financial Services Group first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • PNC Financial Services Group's Merrimack Pharmaceuticals, Inc. position peaked at $306K in Q1 2016.
  • 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.